Find Adverse Event Cases
   _help
Fuzzy Search?
DRUG NAME

 
MANUFACTURER NAME

 
DRUG INDICATION

 
EVENT DESCRIPTION

 
OUTCOME CODE


DRUG'S ROLE CODE


PATIENT GENDER


REPORTER'S OCCUPATION
PATIENT MASS - kg
Lo TO Hi

PATIENT AGE - years
Lo TO Hi
Calendar FDA RECEIPT DATE
TO
There are a Total of 69 Cases for Your Search Forward You Are Viewing Cases 1 to 30 Forward You can View ALL Cases by Requesting a Report Forward    

Drug Name(s) foradil , AND the patient was at most 17 years old


Case # YYQQ ISR Reactions Outcomes Primary Suspect(s) Event Date Manufacturer Age y Mass kg Sex  
3292689 99Q23286444PULMONARY FIBROSIS,SUPERINFECT...HOCASODEX05/26/99ZENECA PHARMACE...1.4 M
  99Q23289089BREATH SOUNDS DECREASED,C-...HOCASODEX05/26/99ZENECA PHARMACE...71.0 M
  99Q23293225ACUTE EXACERBATION OF CHRONIC...HOCASODEX07/26/99ZENECA PHARMACE...71.0 M
  99Q33361134BLOOD CARBON DIOXIDE DECREASED...HOCASODEX05/26/99ZENECA PHARMACE...71.0 M
3324271 99Q33319393ANXIETY NEC,ARTHRALGIA,BACK...HOTHEO-DUR04/14/99SCHERING-PLOUGH...10.0 F
3673777 01Q23745431ADRENAL INSUFFICIENCY NOS,...OTSPORANOX06/01/01JANSSEN RESEARC...12.0 F
  01Q33758521ADRENAL INSUFFICIENCY NOS,...OTSPORANOX06/01/01JANSSEN RESEARC...12.0 F
  01Q33766493ADRENAL INSUFFICIENCY NOS,...OTSPORANOX06/01/01JANSSEN RESEARC...12.0 F
3714934 01Q33800663DYSPNOEA EXERTIONAL,PULMONARY...HOMEGACE06/01/01BRISTOL-MYERS...  M
  02Q33976370DYSPNOEA EXERTIONAL,PULMONARY...HOMEGACE06/01/01BRISTOL-MYERS...10.0 M
3764152 02Q13873068COUGH,RALES,STEVENS JOHNSON...HOMUCOMYST11/22/01BRISTOL-MYERS...14.0 F
3764213 02Q13869660STEVENS JOHNSON SYNDROMEHOFORADIL11/22/01NOVARTIS PHARMA...14.0 F
3775052 02Q13885024AGITATION,HOT FLUSHES NOS,...OTFORADILNOVARTIS PHARMA...8.0 M
  02Q23921907AGITATION,ANAEMIA NOS,BRONCHIT...OTFORADILNOVARTIS PHARMA...8.028.0M
3775058 02Q13885291MULTI-ORGAN FAILUREDEFORADILNOVARTIS PHARMA...7.0 M
  02Q23932883MULTI-ORGAN FAILUREDEFORADILNOVARTIS PHARMA...7.050.0M
3814840 02Q33944802COUGH,HAEMOPTYSISOTFORADIL06/16/02NOVARTIS PHARMA...15.0 M
  02Q43995685COUGH,HAEMOPTYSISOTFORADIL06/06/02NOVARTIS PHARMA...15.0 M
3829245 02Q33961303CUSHING'S SYNDROMEOTSPORANOX01/01/02JOHNSON + JOHNS...4.0 M
  02Q33963606CUSHING'S SYNDROMEOTSPORANOX05/31/02JOHNSON + JOHNS...4.017.0M
  02Q33972134CUSHING'S SYNDROME,HYPERTENSIO...OTSPORANOX05/31/02JOHNSON + JOHNS...4.017.0M
3835956 02Q23933372URINARY INCONTINENCE,URINARY... FORADILNOVARTIS PHARMA...13.0 M
3840945 02Q33975556ASTHMA AGGRAVATED,MARKEDLY...HOFORADIL09/10/02 7.025.4F
3854452 02Q43993596ERYTHEMA MULTIFORMEHOMIFLONIDE(BUDE...09/01/02NOVARTIS PHARMA...7.0 M
3858470 02Q34001952MEDICATION ERROR FORADIL06/18/02NOVARTIS PHARMA...9.0 F
3873671 02Q44020434ANXIETY,PANIC ATTACKOTTONOPAN06/04/02XCEL PHARMACEUT...15.0 F
3887588 03Q14039702CONVULSION NEONATAL,MATERNAL...HORHINOCORT07/21/02ASTRAZENECA...0.02.5M
3915369 03Q14072853ANURIA,BLOOD CREATINE PHOSPHOK...OTVENTOLINGLAXOSMITHKLINE13.0 F
3923606 03Q14078425BLOOD ALBUMIN INCREASED,...OTFORADIL02/01/03NOVARTIS PHARMA...17.062.3M
  03Q14085231HYPOPROTEINAEMIA,NEPHROTIC...OTFORADIL02/01/03NOVARTIS PHARMA...17.062.3M
3927823 03Q14085243LOSS OF CONSCIOUSNESS,NAUSEA,...OTFORADIL03/12/03NOVARTIS PHARMA...12.0 F
  03Q24096663LOSS OF CONSCIOUSNESS,NAUSEA,...OTFORADIL03/12/03NOVARTIS PHARMA...12.025.0F
4009608 03Q34203817UNEVALUABLE EVENTHOADVAIR DISKUS...GLAXOSMITHKLINE8.0 M
4010357 03Q34196243ABDOMINAL DISTENSION,BLOOD...OTITRACONAZOLEJOHNSON +JOHNSO...4.0 M
4045836 04Q34422131ASTHMA,CONDITION AGGRAVATED,...DS,HO,...PREVACID12/01/02TAP PHARMACEUTI...9.030.0F
  03Q34191634ASTHMA,PNEUMONIAHOPREVACID10/01/02TAP PHARMACEUTI...9.030.0F
4071748 03Q34264826BRONCHOSCOPY,CROUP NONINFECTIO...OTFORADIL10/26/03NOVARTIS PHARAM...4.0 F
4103407 04Q14296537EYE REDNESS,EYELID OEDEMA,... STRATTERA08/24/03ELI LILLY AND...11.036.0M
4110239 04Q14317088ASTHMA,COMPLICATIONS OF...DEMESTINON10/01/01VALEANT PHARMAC...0.0 UNK
4120004 04Q24331835ADRENAL SUPPRESSION,FATIGUEOTFLOVENT01/01/03GLAXOSMITHKLINE10.0 F
4129793 04Q14342680ASTHMA,COUGH,DRUG INTERACTION,... STRATTERA11/01/03ELI LILLY AND...7.024.0M
4137333 04Q24353055INJECTION SITE ERYTHEMA,... XOLAIR02/27/04GENENTECH, INC12.054.4M
4137365 04Q24353096INJECTION SITE ERYTHEMA,... XOLAIR02/26/04GENENTECH, INC.15.067.6F
4139224 04Q24353053INJECTION SITE ERYTHEMA,... XOLAIR02/26/04GENENTECH INC17.067.6F

 
2,677,547 adverse event cases, last updated on 08.06.2010 14:41 UTC